Incremental value of epicardial fat volume on predicting obstructive coronary artery disease with myocardial ischemia.
10.3760/cma.j.cn112148-20230105-00008
- VernacularTitle:心外膜脂肪容积预测阻塞性冠心病伴心肌缺血的增益价值
- Author:
Wen Ji YU
1
;
Yong Jun CHEN
2
;
Xiao Yu YANG
2
;
Jian Feng WANG
1
;
Xiao Liang SHAO
1
;
Fei Fei ZHANG
1
;
Bao LIU
1
;
Yue Tao WANG
1
Author Information
1. Department of Nuclear Medicine, the Third Affiliated Hospital of Soochow University, the First People's Hospital of Changzhou, Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou 213003, China.
2. Department of Cardiology, the Third Affiliated Hospital of Soochow University, the First People's Hospital of Changzhou, Changzhou 213003, China.
- Publication Type:Journal Article
- MeSH:
Male;
Humans;
Middle Aged;
Aged;
Female;
Coronary Artery Disease/diagnostic imaging*;
Cross-Sectional Studies;
Retrospective Studies;
Myocardial Ischemia/diagnostic imaging*;
Coronary Stenosis;
Calcium
- From:
Chinese Journal of Cardiology
2023;51(6):633-641
- CountryChina
- Language:Chinese
-
Abstract:
Objective: This study aimed to investigate the association between epicardial fat volume (EFV) and obstructive coronary artery disease (CAD) with myocardial ischemia, and evaluate the incremental value of EFV on top of traditional risk factors and coronary artery calcium (CAC) in predicting obstructive CAD with myocardial ischemia. Methods: This study was a retrospective cross-sectional study. Patients with suspected CAD who underwent coronary angiography (CAG) and single photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) at the Third Affiliated Hospital of Soochow University from March 2018 to November 2019 were consecutively enrolled. EFV and CAC were measured by non-contrast chest computed tomography (CT) scan. Obstructive CAD was defined as coronary artery stenosis≥50% in at least one of the major epicardial coronary arteries, and myocardial ischemia was defined as reversible perfusion defects in stress and rest MPI. Obstructive CAD with myocardial ischemia was defined in patients with coronary stenosis severity≥50% and reversible perfusion defects in the corresponding areas of SPECT-MPI. Patients with myocardial ischemia bot without obstructive CAD were defined as none-obstructive CAD with myocardial ischemia group. We collected and compared the general clinical data, CAC and EFV between the two groups. Multivariable logistic regression analysis was performed to identify the relationship between EFV and obstructive CAD with myocardial ischemia. ROC curves were performed to determine whether addition of EFV improved predictive value beyond traditional risk factors and CAC for obstructive CAD with myocardial ischemia. Results: Among the 164 patients with suspected CAD, 111 patients were males, and average age was (61.4±9.9) years old. 62 (37.8%) patients were included into the obstructive CAD with myocardial ischemia group. 102 (62.2%) patients were included into the none-obstructive CAD with myocardial ischemia group. EFV was significantly higher in obstructive CAD with myocardial ischemia group than in none-obstructive CAD with myocardial ischemia group ((135.63±33.29)cm3 and (105.18±31.16)cm3, P<0.01). Univariate regression analysis showed the risk of obstructive CAD with myocardial ischemia increased by 1.96 times for each SD increase in EFV(OR 2.96; 95%CI, 1.89-4.62; P<0.01). After adjustment for traditional risk factors and CAC, EFV remained as an independent predictor for obstructive CAD with myocardial ischemia (OR, 4.48, 95%CI, 2.17-9.23; P<0.01). Addition of EFV to CAC and traditional risk factors was related to larger AUC for predicting obstructive CAD with myocardial ischemia (0.90 vs. 0.85, P=0.04, 95%CI: 0.85-0.95) and the global chi-square increased by 21.81 (P<0.05). Conclusions: EFV is an independent predictor for obstructive CAD with myocardial ischemia. Addition of EFV to traditional risk factors and CAC has incremental value for predicting obstructive CAD with myocardial ischemia in this patient cohort.
